SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-050911
Filing Date
2008-08-07
Accepted
2008-08-07 16:43:38
Documents
9
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a08-19060_110q.htm 10-Q 1136765
2 EX-3.1,4.1 a08-19060_1ex3d14d1.htm EX-3.1,4.1 148894
3 EX-10.1 a08-19060_1ex10d1.htm EX-10.1 534749
4 EX-10.2 a08-19060_1ex10d2.htm EX-10.2 134128
5 EX-31.1 a08-19060_1ex31d1.htm EX-31.1 12108
6 EX-31.2 a08-19060_1ex31d2.htm EX-31.2 12627
7 EX-32.1 a08-19060_1ex32d1.htm EX-32.1 6191
8 EX-32.2 a08-19060_1ex32d2.htm EX-32.2 5967
9 GRAPHIC g190601ko13i001.jpg GRAPHIC 916
  Complete submission text file 0001104659-08-050911.txt   1994374
Mailing Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14732 | Film No.: 08999162
SIC: 2835 In Vitro & In Vivo Diagnostic Substances